|
HY-122331-100mg
|
MedChemexpress LLC
|
Norbormide [CAS 991-42-4]
|
|
|
|
|
HY-146086-10mg
|
MedChemexpress LLC
|
Nrf2 activator-4 [CAS 2383016-68-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-146086-100mg
|
MedChemexpress LLC
|
Nrf2 activator-4 [CAS 2383016-68-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-146086-25mg
|
MedChemexpress LLC
|
Nrf2 activator-4 [CAS 2383016-68-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-146086-5mg
|
MedChemexpress LLC
|
Nrf2 activator-4 [CAS 2383016-68-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-146086-50mg
|
MedChemexpress LLC
|
Nrf2 activator-4 [CAS 2383016-68-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-12699-10mg
|
MedChemexpress LLC
|
RO5166017 [CAS 1048346-74-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-12699-25mg
|
MedChemexpress LLC
|
RO5166017 [CAS 1048346-74-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-12699-5mg
|
MedChemexpress LLC
|
RO5166017 [CAS 1048346-74-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-12699-50mg
|
MedChemexpress LLC
|
RO5166017 [CAS 1048346-74-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-P73671-10ug
|
MedChemexpress LLC
|
S100A8, Mouse (sf9, His)
|
|
|
|
|
HY-P73671-5ug
|
MedChemexpress LLC
|
S100A8, Mouse (sf9, His)
|
|
|
|
|
HY-P73671-50ug
|
MedChemexpress LLC
|
S100A8, Mouse (sf9, His)
|
|
|
|
|
HY-P76085-10ug
|
MedChemexpress LLC
|
SPINK4, Mouse (HEK293, His)
|
|
|
|
|
HY-P76085-100ug
|
MedChemexpress LLC
|
SPINK4, Mouse (HEK293, His)
|
|
|
|
|
HY-P76085-5ug
|
MedChemexpress LLC
|
SPINK4, Mouse (HEK293, His)
|
|
|
|
|
HY-P76085-50ug
|
MedChemexpress LLC
|
SPINK4, Mouse (HEK293, His)
|
|
|
|
|
HY-P72459-10ug
|
MedChemexpress LLC
|
ST2/IL1RL1, Mouse (HEK293, His)
|
|
|
|
|
HY-P72459-100ug
|
MedChemexpress LLC
|
ST2/IL1RL1, Mouse (HEK293, His)
|
|
|
|
|
HY-P72459-2ug
|
MedChemexpress LLC
|
ST2/IL1RL1, Mouse (HEK293, His)
|
|
|
|
|
HY-P72459-50ug
|
MedChemexpress LLC
|
ST2/IL1RL1, Mouse (HEK293, His)
|
|
|
|
|
HY-P72459-500ug
|
MedChemexpress LLC
|
ST2/IL1RL1, Mouse (HEK293, His)
|
|
|
|
|
HY-13413-10mg
|
MedChemexpress LLC
|
Tofogliflozin (hydrate) [CAS 1201913-82-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-13413-5mg
|
MedChemexpress LLC
|
Tofogliflozin (hydrate) [CAS 1201913-82-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-13413-50mg
|
MedChemexpress LLC
|
Tofogliflozin (hydrate) [CAS 1201913-82-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
